Abstract
PROBLEM BEING ADDRESSED: Family medicine residents frequently interact with pharmaceutical sales representatives (PSRs) during their medical training; the literature indicates that these meetings affect future prescribing habits. We needed to develop a structured approach to PSR visits because our program did not provide residents with a consistent experience in dealing with PSRs. OBJECTIVE OF PROGRAM: To develop a structured approach to PSR visits that would permit residents to better understand the role of PSRs and to gain more from their interactions with PSRs in the future. MAIN COMPONENTS OF PROGRAM: First-year family medicine residents at an academic teaching unit in Edmonton were surveyed on their knowledge and attitude to PSRs and then given a 1-hour educational seminar and five structured visits from PSRs. Following each PSR presentation, residents completed an evaluation form and discussed the interaction with their preceptors. CONCLUSIONS: We believe that a structured educational program is better than a written policy restricting interactions between PSRs and residents for providing residents with an understanding of the role of PSRs and making them better prepared for future contact.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Anastasio G. D., Little J. M., Jr Pharmaceutical marketing: implications for medical residency training. Pharmacotherapy. 1996 Jan-Feb;16(1):103–107. [PubMed] [Google Scholar]
- Avorn J., Chen M., Hartley R. Scientific versus commercial sources of influence on the prescribing behavior of physicians. Am J Med. 1982 Jul;73(1):4–8. doi: 10.1016/0002-9343(82)90911-1. [DOI] [PubMed] [Google Scholar]
- Brotzman G. L., Mark D. H. Policies regulating the activities of pharmaceutical representatives in residency programs. J Fam Pract. 1992 Jan;34(1):54–57. [PubMed] [Google Scholar]
- Brotzman G. L., Mark D. H. Policy recommendations for pharmaceutical representative-resident interactions. Fam Med. 1992 Aug;24(6):431–432. [PubMed] [Google Scholar]
- Chren M. M., Landefeld C. S., Murray T. H. Doctors, drug companies, and gifts. JAMA. 1989 Dec 22;262(24):3448–3451. [PubMed] [Google Scholar]
- Chren M. M., Landefeld C. S. Physicians' behavior and their interactions with drug companies. A controlled study of physicians who requested additions to a hospital drug formulary. JAMA. 1994 Mar 2;271(9):684–689. [PubMed] [Google Scholar]
- Guyatt G. Academic medicine and the pharmaceutical industry: a cautionary tale. CMAJ. 1994 Mar 15;150(6):951–953. [PMC free article] [PubMed] [Google Scholar]
- Lexchin J. Interactions between physicians and the pharmaceutical industry: what does the literature say? CMAJ. 1993 Nov 15;149(10):1401–1407. [PMC free article] [PubMed] [Google Scholar]
- Lurie N., Rich E. C., Simpson D. E., Meyer J., Schiedermayer D. L., Goodman J. L., McKinney W. P. Pharmaceutical representatives in academic medical centers: interaction with faculty and housestaff. J Gen Intern Med. 1990 May-Jun;5(3):240–243. doi: 10.1007/BF02600542. [DOI] [PubMed] [Google Scholar]
- Sergeant M. D., Hodgetts P. G., Godwin M., Walker D. M., McHenry P. Interactions with the pharmaceutical industry: a survey of family medicine residents in Ontario. CMAJ. 1996 Nov 1;155(9):1243–1248. [PMC free article] [PubMed] [Google Scholar]
- Shaughnessy A. F., Slawson D. C., Bennett J. H. Teaching information mastery: evaluating information provided by pharmaceutical representatives. Fam Med. 1995 Oct;27(9):581–585. [PubMed] [Google Scholar]
- Vinson D. C., McCandless B., Hosokawa M. C. Medical students' attitudes toward pharmaceutical marketing: possibilities for change. Fam Med. 1993 Jan;25(1):31–33. [PubMed] [Google Scholar]
- Ziegler M. G., Lew P., Singer B. C. The accuracy of drug information from pharmaceutical sales representatives. JAMA. 1995 Apr 26;273(16):1296–1298. [PubMed] [Google Scholar]